sq-11725 has been researched along with Migraine Disorders in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (57.14) | 18.7374 |
| 1990's | 3 (14.29) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 3 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimizu, T | 1 |
| Artal-Roy, J; García-Gómara, MJ; Gracia-Naya, M; Huerta-Villanueva, M; Latorre-Jiménez, AM; Mauri-Llerda, JA; Ríos-Gómez, C; Sánchez-Valiente, S; Santos-Lasaosa, S | 1 |
| Artal-Roy, J; García-Gomara, MJ; Gracia-Naya, M; Latorre-Jiménez, AM; Mauri-Llerda, JA; Ríos-Gómez, C; Sánchez-Valiente, S; Santos-Lasaosa, S | 1 |
| Artal-Roy, J; Garcia-Gomara, MJ; Gracia-Naya, M; Huerta-Villanueva, M; Latorre-Jimenez, AM; Mauri-Llerda, JA; Rios, C; Sanchez-Valiente, S; Santos-Lasaosa, S | 1 |
| Leira, R; Pascual, J; Rivas, MT | 1 |
| Bilbao, A; Foncea, N; Garcia-Monco, JC; Gomez-Beldarrain, M; Ruiz de Velasco, I | 1 |
| Frishman, WH; Koch-Weser, J | 1 |
| Ryan, RE; Sudilovsky, A | 1 |
| Jackson, EA; Sullman, SA | 1 |
| Schwartz, A; Smith, R | 1 |
| Ryan, RE | 1 |
| Diamond, S; Freitag, FG | 1 |
| Szczudlik, A | 1 |
| Chaturvedi, S; Chugani, DC; Chugani, HT; Fakhouri, M; Lee, ML; Muzik, O; Niimura, K | 1 |
| Bousser, MG; Massiou, H | 1 |
| Ali, S; Mathew, NT | 1 |
| Tfelt-Hansen, P | 1 |
| Pascual, J | 1 |
| Elkind, AH; Meyer, JH; Ryan, RE; Saper, JR; Stern, MA; Sudilovsky, A | 1 |
| Medina, JL | 1 |
| Furberg, B; Gustavsson, CL; Olerud, B | 1 |
4 review(s) available for sq-11725 and Migraine Disorders
| Article | Year |
|---|---|
[Beta blockers in migraine prophylaxis].
Topics: Adrenergic beta-Antagonists; Drug Administration Schedule; Humans; Metoprolol; Migraine Disorders; Nadolol; Premedication; Propranolol | 2009 |
beta-Adrenoceptor antagonists: new drugs and new indications.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Glaucoma; Humans; Hypertension; Kinetics; Metoprolol; Migraine Disorders; Nadolol; Pindolol; Propanolamines; Propranolol; Timolol | 1981 |
Comparative review of beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Atenolol; Humans; Hypertension; Metoprolol; Migraine Disorders; Myocardial Infarction; Nadolol; Pindolol; Propanolamines; Propranolol; Timolol | 1984 |
[Beta-blockers and migraine].
Topics: Adrenergic beta-Antagonists; Atenolol; Clinical Trials as Topic; Dilatation, Pathologic; Evoked Potentials, Visual; Humans; Metoprolol; Migraine Disorders; Nadolol; Platelet Aggregation; Propranolol; Receptors, Serotonin; Timolol | 1992 |
10 trial(s) available for sq-11725 and Migraine Disorders
| Article | Year |
|---|---|
Testing the combination beta-blocker plus topiramate in refractory migraine.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Drug Therapy, Combination; Female; Fructose; Humans; Male; Middle Aged; Migraine Disorders; Nadolol; Neuroprotective Agents; Propranolol; Topiramate; Treatment Outcome | 2007 |
Impact of preventive therapy with nadolol and topiramate on the quality of life of migraine patients.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anticonvulsants; Anxiety; Depression; Female; Fructose; Humans; Male; Middle Aged; Migraine Disorders; Nadolol; Quality of Life; Surveys and Questionnaires; Topiramate | 2007 |
Nadolol: its use in the prophylactic treatment of migraine.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Nadolol; Propanolamines; Random Allocation | 1983 |
Comparative study of nadolol and propranolol in prophylactic treatment of migraine.
Topics: Adrenergic beta-Antagonists; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Nadolol; Propanolamines; Propranolol; Random Allocation | 1984 |
Nadolol and placebo comparison study in the prophylactic treatment of migraine.
Topics: Adrenergic beta-Antagonists; Adult; Female; Humans; Male; Middle Aged; Migraine Disorders; Nadolol; Propanolamines | 1984 |
[Nadolol in the preventive treatment of migraine].
Topics: Adrenergic beta-Antagonists; Adult; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Migraine Disorders; Nadolol; Placebos; Propanolamines; Time Factors | 1984 |
[Beta-blockers and migraine].
Topics: Adrenergic beta-Antagonists; Atenolol; Clinical Trials as Topic; Dilatation, Pathologic; Evoked Potentials, Visual; Humans; Metoprolol; Migraine Disorders; Nadolol; Platelet Aggregation; Propranolol; Receptors, Serotonin; Timolol | 1992 |
Efficacy of beta-blockers in migraine. A critical review.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Double-Blind Method; Humans; Metoprolol; Migraine Disorders; Nadolol; Propranolol; Racemases and Epimerases; Timolol | 1986 |
Comparative efficacy of nadolol and propranolol in the management of migraine.
Topics: Adolescent; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Nadolol; Propranolol; Random Allocation | 1987 |
Nadolol and propranolol in migraine management.
Topics: Adolescent; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Nadolol; Propranolol; Random Allocation | 1986 |
8 other study(ies) available for sq-11725 and Migraine Disorders
| Article | Year |
|---|---|
[Comparative study of the effectiveness of topiramate and nadolol in the preventive treatment of episodic migraine in independent series of patients].
Topics: Adrenergic beta-Antagonists; Adult; Female; Fructose; Humans; Male; Migraine Disorders; Nadolol; Topiramate | 2010 |
[Predisposing factors affecting drop-out rates in preventive treatment in a series of patients with migraine].
Topics: Adrenergic beta-Antagonists; Adult; Anticonvulsants; Female; Flunarizine; Fructose; Humans; Male; Middle Aged; Migraine Disorders; Nadolol; Neuroprotective Agents; Patient Dropouts; Patient Satisfaction; Prospective Studies; Risk Factors; Topiramate; Treatment Outcome; Young Adult | 2011 |
[A study to compare independent groups of patients with episodic migraine who were treated preventively with flunarizine or nadolol].
Topics: Adrenergic beta-Antagonists; Adult; Calcium Channel Blockers; Female; Flunarizine; Humans; Male; Migraine Disorders; Nadolol | 2012 |
Diltiazem prophylaxis in refractory migraine.
Topics: Adrenergic beta-Antagonists; Adult; Benzazepines; Diltiazem; Female; Humans; Male; Middle Aged; Migraine Disorders; Nadolol; Pilot Projects; Propanolamines | 1984 |
Increased brain serotonin synthesis in migraine.
Topics: Adrenergic beta-Antagonists; Adult; Brain; Female; Humans; Middle Aged; Migraine Disorders; Nadolol; Propranolol; Radionuclide Imaging; Reference Values; Serotonin | 1999 |
Tachyphylaxis in migraine prophylaxis.
Topics: Humans; Methysergide; Migraine Disorders; Nadolol; Retrospective Studies; Tachyphylaxis | 1992 |
"Nadolol in migrainous patients".
Topics: Humans; Migraine Disorders; Nadolol | 1988 |
Effectiveness of nadolol in a clinic population of migrainous patients.
Topics: Adolescent; Adult; Antidepressive Agents; Female; Humans; Male; Middle Aged; Migraine Disorders; Muscle Contraction; Nadolol; Propranolol; Prospective Studies | 1988 |